← All trials
NCT00789776
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2008
- Primary completion
- Jun 1, 2017
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 42
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of WashingtonLead sponsor
- The Wayne D. Kuni and Joan E. Kuni FoundationCollaborator
- University of WashingtonOverall official - principal investigator
- National Cancer Institute (NCI)Collaborator
Drugs studied
Indications studied
- Hodgkin Disease
- Lymphoma, Non-Hodgkin
- Waldenstrom Macroglobulinemia
- Multiple Myeloma
- Myelodysplastic Syndromes
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myeloid, Acute
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Lymphoma, Primary Cutaneous Anaplastic Large Cell
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.